Lao People’s Democratic Republic (PDR) government is giving the highest priority to the healthcare sector, and this is creating a good opportunity for foreign country manufacturers like Indian and China to export low-cost high-quality generic drugs into Laos. Lao’s is a small country with a very small market for medical, health, and other pharmaceuticals. The […]

Read More →

There is a growing demand for generic drugs in Malaysia. The government is the largest pharmaceutical buyer in Malaysia and is responsible for more than half of the purchasing value. The Indian, Chinese, and other similar drug manufacturers have begun playing a dominant role in the Malaysian pharmaceutical market. In Malaysia, the pharmaceutical manufacturing sector […]

Read More →

Indonesia’s pharmaceutical market is the largest market in the Association of Southeast Nations (ASEAN). The current pharmaceutical market is worth IDR 84 trillion (USD 6 billion) and is expected to reach $10.11 billion by 2021.  Some interesting facts about Indonesia The Indonesian Pharmacists Association reported that about 95 percent of raw material for medicine is […]

Read More →

The Asia-Pacific region is emerging as a new destination for generic drugs. The Asia-pacific market is forecasted to grow from USD 75 billion in 2020 to USD 112 billion by 2025 at a CAGR of 8.34%. The growth of the generic drugs market is accelerated by many factors such as the aging population, increasing pharmaceutical […]

Read More →

The demand for healthcare products and services has been growing in ASEAN countries. Governments start facing the same problem as in more developed countries and struggle to finance the growing healthcare expenses. There is a steep increase in chronic diseases along with infectious diseases. This is creating an opportunity for the generic drug manufacturers to […]

Read More →

Singapore has become a global center for the pharmaceutical industry due to the cost-effective and reliable medical services, high-quality pharmaceutical manufacturing and research, access to regional markets, and a skilled workforce. Also, the Government has supported several schemes to drive innovation and development. This has created in many manufacturers to register their generic products in […]

Read More →

The Philippines is the third-largest pharmaceutical market in ASEAN after Thailand and Indonesia. In 2019, total generic drug sales were in the Philippines were PHP82.3 billion, and accounts for 63% of prescription sales and estimate to reach PHP110 Billion by 2024. The highest cost of medicines in the Philippines among other ASEAN countries is one […]

Read More →

Myanmar’s pharmaceutical market size was $456 million in 2017, with a percapita pharma expenditure of $8.5 and expected to reach $656 million in 2022. Myanmar’s economy is growing continuously, and the experts predict the pharmaceutical industry to quickly grow into a $1.12 billion industry in the future. Myanmar depends on the import of pharmaceutical products […]

Read More →